Phase Ib study of heat shock protein 90 inhibitor, onalespib in combination with paclitaxel in patients with advanced, triple negative breast cancer (NCT02474173)

MLA

Julie A. Stephens, et al. “Phase Ib Study of Heat Shock Protein 90 Inhibitor, Onalespib in Combination with Paclitaxel in Patients with Advanced, Triple Negative Breast Cancer (NCT02474173).” Annals of Oncology, vol. 30, Oct. 2019, p. v126. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........95e29dfdb2f803bea9881de5d4ce4136&authtype=sso&custid=ns315887.

APA

Julie A. Stephens, S. Bhattacharya, Robert Wesolowski, Anne M. Noonan, William E. Carson, B Ramaswamy, Mitch A. Phelps, Adam Brufsky, M. Chambers, Jeffrey VanDeusen, Sagar Sardesai, Michael R. Grever, Maryam B. Lustberg, & Nita Williams. (2019). Phase Ib study of heat shock protein 90 inhibitor, onalespib in combination with paclitaxel in patients with advanced, triple negative breast cancer (NCT02474173). Annals of Oncology, 30, v126.

Chicago

Julie A. Stephens, S. Bhattacharya, Robert Wesolowski, Anne M. Noonan, William E. Carson, B Ramaswamy, Mitch A. Phelps, et al. 2019. “Phase Ib Study of Heat Shock Protein 90 Inhibitor, Onalespib in Combination with Paclitaxel in Patients with Advanced, Triple Negative Breast Cancer (NCT02474173).” Annals of Oncology 30 (October): v126. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........95e29dfdb2f803bea9881de5d4ce4136&authtype=sso&custid=ns315887.